Hilsenbeck SG - Search Results

1

The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer.

Ma XJ, Hilsenbeck SG, Wang W, Ding L, Sgroi DC, Bender RA, Osborne CK, Allred DC, Erlander MG. Ma XJ, et al. Among authors: hilsenbeck sg. J Clin Oncol. 2006 Oct 1;24(28):4611-9. doi: 10.1200/JCO.2006.06.6944. J Clin Oncol. 2006. PMID: 17008703

2

Improved methods of estimating mitotic activity in solid tumors.

Hilsenbeck SG, Allred DC. Hilsenbeck SG, et al. Hum Pathol. 1992 Jun;23(6):601-2. doi: 10.1016/0046-8177(92)90312-q. Hum Pathol. 1992. PMID: 1592380 No abstract available.

3

Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer.

Osborne CK, Coronado-Heinsohn EB, Hilsenbeck SG, McCue BL, Wakeling AE, McClelland RA, Manning DL, Nicholson RI. Osborne CK, et al. Among authors: hilsenbeck sg. J Natl Cancer Inst. 1995 May 17;87(10):746-50. doi: 10.1093/jnci/87.10.746. J Natl Cancer Inst. 1995. PMID: 7563152

4

Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer.

Isola JJ, Kallioniemi OP, Chu LW, Fuqua SA, Hilsenbeck SG, Osborne CK, Waldman FM. Isola JJ, et al. Among authors: hilsenbeck sg. Am J Pathol. 1995 Oct;147(4):905-11. Am J Pathol. 1995. PMID: 7573366 Free PMC article.

5

Inhibition of estrogen-induced breast cancer cell proliferation by reduction in autocrine transforming growth factor alpha expression.

Reddy KB, Yee D, Hilsenbeck SG, Coffey RJ, Osborne CK. Reddy KB, et al. Among authors: hilsenbeck sg. Cell Growth Differ. 1994 Dec;5(12):1275-82. Cell Growth Differ. 1994. PMID: 7696176

6

Prognostic factors: rationale and methods of analysis and integration.

Clark GM, Hilsenbeck SG, Ravdin PM, De Laurentiis M, Osborne CK. Clark GM, et al. Among authors: hilsenbeck sg. Breast Cancer Res Treat. 1994;32(1):105-12. doi: 10.1007/BF00666211. Breast Cancer Res Treat. 1994. PMID: 7819579 Review.

7

Heat shock proteins and drug resistance.

Fuqua SA, Oesterreich S, Hilsenbeck SG, Von Hoff DD, Eckardt J, Osborne CK. Fuqua SA, et al. Among authors: hilsenbeck sg. Breast Cancer Res Treat. 1994;32(1):67-71. doi: 10.1007/BF00666207. Breast Cancer Res Treat. 1994. PMID: 7819588 Review.

8

The importance of tamoxifen metabolism in tamoxifen-stimulated breast tumor growth.

Osborne CK, Jarman M, McCague R, Coronado EB, Hilsenbeck SG, Wakeling AE. Osborne CK, et al. Among authors: hilsenbeck sg. Cancer Chemother Pharmacol. 1994;34(2):89-95. doi: 10.1007/BF00685924. Cancer Chemother Pharmacol. 1994. PMID: 8194171

9

p53 is mutated in a subset of advanced-stage prostate cancers.

Bookstein R, MacGrogan D, Hilsenbeck SG, Sharkey F, Allred DC. Bookstein R, et al. Among authors: hilsenbeck sg. Cancer Res. 1993 Jul 15;53(14):3369-73. Cancer Res. 1993. PMID: 8324747

10

WAF1/CIP1 protein expression in human breast tumors.

Diab SG, Yu YY, Hilsenbeck SG, Allred DC, Elledge RM. Diab SG, et al. Among authors: hilsenbeck sg. Breast Cancer Res Treat. 1997 Apr;43(2):99-103. doi: 10.1023/a:1005752829260. Breast Cancer Res Treat. 1997. PMID: 9131264

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

370 results

Search Page

Filters